The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The cardiovascular surgery devices and equipment market have demonstrated steady growth, reflecting its pivotal role in addressing the challenges posed by cardiovascular diseases. With a market size projected to reach $1.87 billion in 2024, witnessing a compound annual growth rate (CAGR) of 4.5%, the industry is evolving. The historical growth is attributed to the prevalence of cardiovascular diseases, technological advancements, an aging population, and the need for effective chronic disease management.

Current Landscape and Future Projections

The current landscape sets the stage for continued growth, with projections indicating a steady climb from $1.79 billion in 2023 to $2.16 billion in 2028, boasting a CAGR of 3.6%. The anticipated surge is driven by factors such as the adoption of minimally invasive surgery, advanced imaging techniques, personalized medicine, and the growing influence of telemedicine and teleconsultations. Notable trends in the forecast period include the rise of hybrid operating rooms, transcatheter procedures, the integration of artificial intelligence (AI) in surgery, and remote surgical training.

Growing Geriatric Population And Cardiovascular Mortality Rates Propel The Cardiovascular Surgical Devices Market

The surging geriatric population, coupled with the rising mortality rates associated with cardiovascular disorders, is a significant driver for the cardiovascular surgical devices market. In the United States alone, approximately 43.7 million individuals aged above 60 suffer from cardiovascular disorders, according to the American Heart Association (AHA). The global death toll related to cardiac diseases, reported by AHA, is expected to rise from 17.3 million per year to more than 23.6 million by 2030. This alarming scenario propels an increasing number of surgeries, thereby driving market growth. Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Abiomed Inc., and Medtronic PLC.

View More On The Cardiovascular Surgery Devices And Equipment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Innovations In Second-Generation Bioresorbable Stents Fuel Growth In The Cardiovascular Surgery Devices Market

Companies within the cardiovascular surgery devices and equipment market are investing in second-generation bioresorbable stents, rectifying glitches from earlier versions. This advancing segment is projected to reach $247 million by 2025. The introduction of features such as thinner strut thicknesses, faster resorption times, and enhanced radial force contributes to their expected higher growth rate. Bioresorbable stents’ adoption is driven by a higher elective procedure volume, thanks to the less-invasive nature of percutaneous coronary interventions (PCIs) compared to coronary artery bypass grafting. Notably, Amaranth Medical has developed medical devices with a thinner strut thickness, the latest boasting 100 microns.

FDA’s Transparent Approval Priorities Signal Positive Outlook For The Cardiovascular Surgical Devices Market

The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has unveiled a priority list for medical device guidance documents. This transparency aids companies in promoting innovation while providing a clearer and more efficient approval process. Such initiatives are expected to drive the cardiovascular surgical devices market, fostering innovation and alleviating the stringent consequences of non-approval. A transparent approval method will contribute to a positive outlook for the market.

Market Segmentation

Understanding the diverse facets of cardiovascular surgery, the market is segmented based on product types, applications, and end-users.

1. By Product Type:
   • Beating Heart Surgery Systems
   • Cardiopulmonary Bypass Equipment
   • Cardiac Ablation Devices
   • Perfusion Disposables
2. By Application:
   • Congenital Heart Defects
   • Cardiac Arrhythmia
   • Coronary Heart Disease
   • Congestive Heart Failure
   • Other Applications
3. By End User:
   • Home and Ambulatory Care
   • Hospitals
   • Diagnostic Laboratories
   • Research Laboratories

Regional Dominance

As of 2023, North America stands out as the largest region in the global cardiovascular surgery devices and equipment market, underscoring the region’s significant role in steering market dynamics.

Conclusion

The cardiovascular surgery devices and equipment market’s trajectory is marked by steady growth, fueled by demographic shifts, technological innovations, and a focus on mitigating cardiovascular diseases. As the market continues to evolve, companies must remain vigilant, embracing advancements in minimally invasive procedures, AI integration, and the broader adoption of telemedicine. The road ahead promises not only financial growth but also advancements that contribute to improved patient outcomes and enhanced healthcare practices in cardiovascular surgery.

Request A Sample Of The Global Cardiovascular Surgery Devices And Equipment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=2389&type=smp

About Company:  TBRC  

As a premier market research firm, we specialize in delivering comprehensive insights into customer behavior, market trends, product landscapes, and competitor analysis. Our expertise lies in extracting actionable intelligence through methods such as secondary research, expert interviews, proprietary data, and our extensive in-house knowledge base. With a dedicated team of over 350 experts spanning 28 countries, we curate a repository of 1.5 million datasets across 27 diverse industries, including services, manufacturing, healthcare, financial services, and technology. Our tailored intelligence services empower strategic decision-making, guiding you in market selection, customer targeting, and outmaneuvering competitors.